Abstract
558 - Low-Dose Azacitidine and Venetoclax Maintenance Following Allogeneic Hematopoietic Stem Cell Transplantation in High-Risk AML and MDS Patients: Single Center Retrospective Analysis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have